You are using an older browser version. Please use a supported version for the best MSN experience.

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Gavino Garay reports.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon